Spyridon Georgakopoulos
Spyridon Georgakopoulos has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Irene Lidoriki
Department of Environmental, Occupational Medicine and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
2 shared publications - Stefanos N. Kales
Harvard Medical School
2 shared publications - Bogdan Andjelic
Applied Bioenergetics Laboratory, Medical Polyclinic Fizikus, 11000 Belgrade, Serbia
1 shared publication - Costas A. Christophi
Cyprus International Institute for Environmental and Public Health, School of Health Sciences, Cyprus University of Technology, Limassol, Cyprus
1 shared publication - Eleni Melliou
Laboratory of Pharmacognosy and Natural Products Chemistry, Department of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, Athens 15771, Greece
1 shared publication - Eleni Speros
Massachusetts College of Pharmacy and Health Sciences, Boston, MA 02115, USA
1 shared publication
Latest Publications
- Open Access
- 9 September 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (18) , 9877
Nutritional Analysis of Bottarga and Pilot Study Protocol for Bottarga Supplementation in Individuals with Prediabetes
Background: Bottarga is a nutrient-dense, marine (“blue”) food produced through sustainable practices. Despite its rich nutritional profile, no clinical studies have investigated its potential health benefits in humans. This study presents a comprehensive nutritional analysis of a commercially available Greek bottarga and outlines the protocol for a pilot clinical investigation to assess its metabolic effects. Methods: The lipid composition of bottarga was analyzed using proton and carbon nuclear magnetic resonance spectroscopy. The clinical protocol consists of two phases: aim 1 is a single-arm, open-label, dose-confirmation study in five overweight and prediabetic adults evaluating the effects of daily bottarga supplementation (20 g/day) over six weeks on metabolic markers; aim 2 is a randomized, open-label, controlled, cross-over pilot study involving 20 overweight and prediabetic participants. Each participant will receive either bottarga or an isocaloric dairy comparator for eight weeks, separated by a two-week washout period. The primary outcome will be selected based on the most clinically relevant findings from Aim 1. Results: According to our nutritional analysis, wax esters are the predominant lipid class in the product, followed by triacylglycerols and free fatty acids. We expect bottarga supplementation to be associated with more beneficial metabolic changes compared to baseline measures and to the calorically equivalent comparator food. Conclusions: This study will provide the first clinical data on the metabolic effects of bottarga in humans, potentially supporting it as a functional food for cardiometabolic health.
- 9 September 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (18) , 9877
Open AccessNutritional Analysis of Bottarga and Pilot Study Protocol for Bottarga Supplementation in Individuals with Prediabetes
Background: Bottarga is a nutrient-dense, marine (“blue”) food produced through sustainable practices. Despite its rich nutritional profile, no clinical studies have investigated its potential health benefits in humans. This study presents a comprehensive nutritional analysis of a commercially available Greek bottarga and outlines the protocol for a pilot clinical investigation to assess its metabolic effects. Methods: The lipid composition of bottarga was analyzed using proton and carbon nuclear magnetic resonance spectroscopy. The clinical protocol consists of two phases: aim 1 is a single-arm, open-label, dose-confirmation study in five overweight and prediabetic adults evaluating the effects of daily bottarga supplementation (20 g/day) over six weeks on metabolic markers; aim 2 is a randomized, open-label, controlled, cross-over pilot study involving 20 overweight and prediabetic participants. Each participant will receive either bottarga or an isocaloric dairy comparator for eight weeks, separated by a two-week washout period. The primary outcome will be selected based on the most clinically relevant findings from Aim 1. Results: According to our nutritional analysis, wax esters are the predominant lipid class in the product, followed by triacylglycerols and free fatty acids. We expect bottarga supplementation to be associated with more beneficial metabolic changes compared to baseline measures and to the calorically equivalent comparator food. Conclusions: This study will provide the first clinical data on the metabolic effects of bottarga in humans, potentially supporting it as a functional food for cardiometabolic health.
- Open Access
Beta and Pilot Testing of the Surviving & Thriving Healthy Lifestyle App: A Countermeasure to Firefighters’ Occupational Health Risks
Background: Firefighters face elevated chronic disease risks, and interventions promoting healthier lifestyles are essential for improving their well-being. This study aimed to beta test and further evaluate a healthy lifestyle app (HLS app) for firefighters. Methods: Beta usability testing was conducted with new firefighters after using the app. Pilot testing was conducted in two cohorts, (1) the Connecticut Fire Academy Class A-CCA after graduation and (2) the Connecticut Class B-CCB and Miami-Dade Fire Rescue Academy, during academy training to evaluate the potential efficacy of the HLS app in improving healthy lifestyle behaviors, mental health, and physical fitness over three months of use. Results: Beta testing (n = 93) revealed positive usability feedback, with 62% finding it useful for their health. Pilot testing after graduation (n = 28) was associated with increased push-up capacity (35.6 ± 11.7 vs. 42.9 ± 16.1, p = 0.006) and improved mental health scores. Pilot testing during academy training (n = 90) was associated with improvements in push-up capacity (33.8 ± 10.8 vs. 41 ± 10.6, p < 0.001), pull-ups (7 [4–11] vs. 10.5 [6–14], p < 0.001), 1.5-mile run time (11.96 ± 1.43 vs. 11.26 ± 1.1, p < 0.001), BMI (26.7 [24.3–29.7] vs. 25.95 [24.0–28.8], p < 0.001), and mental health scores. Conclusions: The app was well received and showed potential for improving firefighter health. A randomized controlled trial is needed to rigorously evaluate the effectiveness of the HLS app.
Open AccessBeta and Pilot Testing of the Surviving & Thriving Healthy Lifestyle App: A Countermeasure to Firefighters’ Occupational Health Risks
Background: Firefighters face elevated chronic disease risks, and interventions promoting healthier lifestyles are essential for improving their well-being. This study aimed to beta test and further evaluate a healthy lifestyle app (HLS app) for firefighters. Methods: Beta usability testing was conducted with new firefighters after using the app. Pilot testing was conducted in two cohorts, (1) the Connecticut Fire Academy Class A-CCA after graduation and (2) the Connecticut Class B-CCB and Miami-Dade Fire Rescue Academy, during academy training to evaluate the potential efficacy of the HLS app in improving healthy lifestyle behaviors, mental health, and physical fitness over three months of use. Results: Beta testing (n = 93) revealed positive usability feedback, with 62% finding it useful for their health. Pilot testing after graduation (n = 28) was associated with increased push-up capacity (35.6 ± 11.7 vs. 42.9 ± 16.1, p = 0.006) and improved mental health scores. Pilot testing during academy training (n = 90) was associated with improvements in push-up capacity (33.8 ± 10.8 vs. 41 ± 10.6, p < 0.001), pull-ups (7 [4–11] vs. 10.5 [6–14], p < 0.001), 1.5-mile run time (11.96 ± 1.43 vs. 11.26 ± 1.1, p < 0.001), BMI (26.7 [24.3–29.7] vs. 25.95 [24.0–28.8], p < 0.001), and mental health scores. Conclusions: The app was well received and showed potential for improving firefighter health. A randomized controlled trial is needed to rigorously evaluate the effectiveness of the HLS app.